Overweight Children With Asthma Less Likely to Respond to Treatment
Higher body mass index tied to poor response to inhaled corticosteroids
Asthma
Albuterol/Budesonide Fixed-Dose Combo Looks Promising in Asthma Trials
The combination therapy significantly reduced the risk of severe exacerbations and improved lung function.
Intravenous Magnesium in ED Linked to Hospitalization for Pediatric Asthma
Researchers investigated whether use of intravenous magnesium therapy for children with asthma was linked to subsequent hospitalization of these children.
Tezepelumab Gets Priority Review for Severe Asthma
The BLA submission included data from the pivotal phase 3 NAVIGATOR trial that assessed tezepelumab in 1061 patients with severe, uncontrolled asthma.
Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma
Data mining resulted in 2006 reports of anaphylaxis related to the use of 5 mAbs.
High Levels of Fractional Exhaled Nitric Oxide Associated With Severe Asthma Exacerbations
Patients with severe asthma who had high levels of fractional exhaled nitric oxide (FeNO) were more likely to have asthma exacerbations than those with low levels.
Spirometry Measurements Obtained at Home vs Clinic Evaluated
Spirometry measurements obtained at home had poor agreement with results obtained in the clinic.
Asthma, COPD Do Not Increase Mortality Risk in Patients With COVID-19
Asthma and chronic obstructive pulmonary disease (COPD) do not appear to increase the risk of mortality in patients with COVID-19.
Dupilumab Effective in Treating OCS-Dependent Asthma, Weaning OCS Use
Long-term treatment of oral corticosteroid (OCS)-dependent asthma with dupilumab has shown efficacy in weaning off OCS while improving lung function.
Proof-of-Concept Biomarker-Based Scale Can Predict Asthma Attacks
The novel ORACLE scale (Oxford Asthma Attack Risk Scale) demonstrated potential to predict — and subsequently prevent — asthma attacks using biomarkers of type 2 airway inflammation.
